AROS Is a Significant Biomarker for Tumor Aggressiveness in Non-cirrhotic Hepatocellular Carcinoma

Despite a low risk of liver failure and preserved liver function, non-cirrhotic hepatocellular carcinoma (HCC) has a poor prognosis. In the current study, we evaluated an active regulator of SIRT1 (AROS) as a prognostic biomarker in non-cirrhotic HCC. mRNA levels of AROS were measured in tumor and n...

全面介紹

Na minha lista:
書目詳細資料
發表在:J Korean Med Sci
Main Authors: Kwon, Jung-Hee, Ahn, Keun Soo, Moon, Young Ho, Park, Jin Young, Wang, Hee Jung, Choi, Kwan Yong, Kim, Gundo, Joh, Jae Won, Lee, Kyeong Geun, Kang, Koo Jeong
格式: Artigo
語言:Inglês
出版: The Korean Academy of Medical Sciences 2015
主題:
Original Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4553671/
https://ncbi.nlm.nih.gov/pubmed/26339164
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3346/jkms.2015.30.9.1253
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍